Bradycardia Treatment Devices Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Bradycardia Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Sinus Bradycardia, Sinus Pause, Sick Sinus Syndrome, Tachy-brady Syndrome, Heart Block), By Devices (Pacemakers {Single Chamber Pacemaker, Dual Chamber Pacemaker}, Defibrillator), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Bradycardia Treatment Devices Market is anticipated to expand significantly, projected to grow from USD 10.09 Billion in 2025 to USD 13.87 Billion by 2031, at a Compound Annual Growth Rate (CAGR) of 5.45%. These implantable medical systems are designed to continuously monitor cardiac rhythm and deliver electrical impulses when the heart rate drops below a critical threshold. The market's primary expansion is driven by the globally aging population, which directly correlates with an increased incidence of conduction system disorders like atrioventricular block, and the rising prevalence of concurrent cardiovascular conditions necessitating consistent therapeutic interventions.
Market Driver
Technological advancements in cardiac pacemaker systems are fundamentally reshaping the market, addressing previous clinical limitations of traditional transvenous implants. A significant trend is the shift towards leadless pacing options, including dual-chamber systems, which eliminate complications such as lead fractures and pocket infections while simultaneously improving patient comfort and recovery times. This innovation directly translates into enhanced financial performance for major manufacturers as they transition their product portfolios to these next-generation devices, as exemplified by Abbott's Rhythm Management segment achieving 7% growth in Q3 2024, largely driven by the strong adoption of the AVEIR leadless pacemaker. Concurrently, the rising prevalence of cardiovascular diseases remains a foundational catalyst for the sustained demand for bradycardia therapies. As the global population ages, the incidence of conduction system disorders and arrhythmias increases, necessitating a higher volume of device interventions to maintain hemodynamic stability. The American Heart Association's 2024 statistics estimated approximately 127.9 million adults in the United States alone had some form of cardiovascular disease, underscoring the critical need for rhythm management solutions, which is reflected in the robust activity of the broader sector, with Boston Scientific's Cardiology division generating $2.129 billion in net sales in Q3 2024.
Market Challenge
The Global Bradycardia Treatment Devices Market faces a substantial obstacle in the form of post-implantation complications, predominantly infections and lead dislodgement, which often necessitate risky and expensive repeat surgeries. These adverse events fundamentally hinder market growth by inflating the long-term cost of care and introducing liability concerns that can deter the adoption of implantable therapies. When a device fails or an infection occurs, the required revision procedure is typically more complex than the initial implantation, consuming a disproportionate amount of healthcare resources and diminishing the overall economic efficiency of these rhythm management solutions. The scale of this challenge is evident in recent procedural volumes; for instance, the German Society for Thoracic and Cardiovascular Surgery reported a total of 20,114 pacemaker and implantable cardioverter-defibrillator procedures in 2024, indicating that even a fractional complication rate results in a significant number of "redo" operations. Such procedures are consistently identified as carrying higher mortality rates and financial burdens compared to primary implants, thus straining hospital budgets and affecting market expansion.
Market Trends
A significant clinical shift towards conduction system pacing techniques is redefining implantation strategies by prioritizing physiological ventricular activation over traditional right ventricular apical pacing. This approach, specifically utilizing His bundle or left bundle branch area pacing, mitigates the risk of pacing-induced cardiomyopathy and preserves long-term cardiac synchrony, with manufacturers actively validating their existing lead portfolios to meet the growing electrophysiological demand for physiological pacing solutions, as demonstrated by Boston Scientific's September 2024 FDA approval to expand the indication of its INGEVITY+ pacing leads for conduction system pacing. Concurrently, the integration of AI algorithms for enhanced diagnostic accuracy is addressing the critical challenge of data overload associated with continuous cardiac monitoring. As insertable cardiac monitors generate vast datasets, artificial intelligence proves essential for filtering signal noise and significantly reducing the burden of false-positive notifications that frequently overwhelm clinical workflows. This technological integration ensures physicians can focus solely on actionable arrhythmia events, thereby improving diagnostic confidence and operational efficiency, as Medtronic's May 2024 announcement showed advanced AccuRhythm AI algorithms reducing false alerts for atrial fibrillation and pause episodes by up to 85%.
Key Market Players
* Medtronic plc
* Abbott Laboratories
* Boston Scientific Corporation
* Biotronik SE & Co. KG
* MicroPort Scientific Corporation
* Osypka Medical GmbH
* Lepu Medical Technology (Beijing) Co., Ltd.
* Nihon Kohden Corporation
* Medico S.R.L.
* Zoll Medical Corporation
Report Scope
In this report, the Global Bradycardia Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Bradycardia Treatment Devices Market, By Type
* Sinus Bradycardia
* Sinus Pause
* Sick Sinus Syndrome
* Tachy-brady Syndrome
* Heart Block
# Bradycardia Treatment Devices Market, By Devices
* Pacemakers
* Defibrillator
# Bradycardia Treatment Devices Market, By End User
* Hospitals & Clinics
* Ambulatory Care Centers
* Others
# Bradycardia Treatment Devices Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bradycardia Treatment Devices Market.
Available Customizations:
Global Bradycardia Treatment Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Bradycardia Treatment Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Sinus Bradycardia, Sinus Pause, Sick Sinus Syndrome, Tachy-brady Syndrome, Heart Block)
5.2.2. By Devices (Pacemakers {Single Chamber Pacemaker, Dual Chamber Pacemaker}, Defibrillator)
5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Bradycardia Treatment Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Devices
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Bradycardia Treatment Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Devices
6.3.1.2.3. By End User
6.3.2. Canada Bradycardia Treatment Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Devices
6.3.2.2.3. By End User
6.3.3. Mexico Bradycardia Treatment Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Devices
6.3.3.2.3. By End User
7. Europe Bradycardia Treatment Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Devices
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Bradycardia Treatment Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Devices
7.3.1.2.3. By End User
7.3.2. France Bradycardia Treatment Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Devices
7.3.2.2.3. By End User
7.3.3. United Kingdom Bradycardia Treatment Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Devices
7.3.3.2.3. By End User
7.3.4. Italy Bradycardia Treatment Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Devices
7.3.4.2.3. By End User
7.3.5. Spain Bradycardia Treatment Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Devices
7.3.5.2.3. By End User
8. Asia Pacific Bradycardia Treatment Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Devices
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Bradycardia Treatment Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Devices
8.3.1.2.3. By End User
8.3.2. India Bradycardia Treatment Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Devices
8.3.2.2.3. By End User
8.3.3. Japan Bradycardia Treatment Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Devices
8.3.3.2.3. By End User
8.3.4. South Korea Bradycardia Treatment Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Devices
8.3.4.2.3. By End User
8.3.5. Australia Bradycardia Treatment Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Devices
8.3.5.2.3. By End User
9. Middle East & Africa Bradycardia Treatment Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Devices
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Bradycardia Treatment Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Devices
9.3.1.2.3. By End User
9.3.2. UAE Bradycardia Treatment Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Devices
9.3.2.2.3. By End User
9.3.3. South Africa Bradycardia Treatment Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Devices
9.3.3.2.3. By End User
10. South America Bradycardia Treatment Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Devices
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Bradycardia Treatment Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Devices
10.3.1.2.3. By End User
10.3.2. Colombia Bradycardia Treatment Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Devices
10.3.2.2.3. By End User
10.3.3. Argentina Bradycardia Treatment Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Devices
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Bradycardia Treatment Devices Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Medtronic plc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Abbott Laboratories
15.3. Boston Scientific Corporation
15.4. Biotronik SE & Co. KG
15.5. MicroPort Scientific Corporation
15.6. Osypka Medical GmbH
15.7. Lepu Medical Technology (Beijing) Co., Ltd.
15.8. Nihon Kohden Corporation
15.9. Medico S.R.L.
15.10. Zoll Medical Corporation
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們